%! Author = csefalvayk
%! Date = 7/4/21
\documentclass{article}
\usepackage{amsfonts}
\usepackage{url}


% Bibliography styling
\usepackage[super,square,sort&compress,numbers]{natbib}
\bibliographystyle{unsrtnat}
\usepackage{graphicx}

\title{VAERS data reveals no increased risk of neuroautoimmune adverse events from COVID-19 vaccines}

% Authors, for the paper (add full first names)
\author{Chris von Csefalvay\thanks{Starschema Inc., Arlington, VA. Correspondence: \texttt{csefalvayk@starschema.net}.}}

\begin{document}

	\maketitle

\begin{abstract}
TBD.
\end{abstract}

\section{Introduction}
	
\section{Materials and methods}

\subsection{Defining cases and exposures}	
	
\subsection{Case-control matching}
	
\subsection{Statistical analysis}
	
\section{Results}

\section{Discussion}


% Document
\begin{document}


%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
\vspace{6pt}

\section*{Funding}

This research was funded by Starschema Inc. under its intramural research funding programme.

\section*{Data availability}

VAERS reporting data is available from the CDC's website at \url{https://vaers.hhs.gov}.
All code and scripts supporting this manuscript are deposited at
\url{https://github.com/chrisvoncsefalvay/covid-19-autommune-aefis} and are made available under the DOI 10.5281/XXXXXXX.

\section*{Conflicts of interest}

CvC is a consultant to a company that may be affected by the research reported in this paper.
The funders had no role in the design of the study;
in the collection, analysis, or interpretation of data;
in the writing of the manuscript, or in the decision to publish the~results.


\section*{References}

\bibliography{bibliography}

\end{document}
